Publications by Heidi Glosli
43 publications found
Original articles
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
Haemophilia (in press)
DOI 10.1111/hae.15019, PubMed 38632836
Bleeding control improves after switching to emicizumab: Real-world experience of 177 children in the PedNet registry
Haemophilia (in press)
DOI 10.1111/hae.15015, PubMed 38578720
Quantitative diffusion-weighted MRI response assessment in rhabdomyosarcoma: an international retrospective study on behalf of the European paediatric Soft tissue sarcoma Study Group Imaging Committee
Pediatr Radiol, 53 (12), 2539-2551
DOI 10.1007/s00247-023-05745-z, PubMed 37682330
Effect of Music Therapy on Parent-Infant Bonding Among Infants Born Preterm: A Randomized Clinical Trial
JAMA Netw Open, 6 (5), e2315750
DOI 10.1001/jamanetworkopen.2023.15750, PubMed 37234006
Factors associated with physical activity in young people with haemophilia A on prophylaxis
Haemophilia, 29 (3), 900-909
DOI 10.1111/hae.14776, PubMed 36913380
Nonmetastatic Rhabdomyosarcoma in Children and Adolescents: Overall Results of the European Pediatric Soft Tissue Sarcoma Study Group RMS2005 Study
J Clin Oncol, 41 (13), 2342-2349
DOI 10.1200/JCO.22.02093, PubMed 36848614
Physical activity in Norwegian teenagers and young adults with haemophilia A compared to general population peers
Haemophilia, 29 (2), 658-667
DOI 10.1111/hae.14752, PubMed 36723510
BAY 81-8973 Efficacy and Safety in Previously Untreated and Minimally Treated Children with Severe Hemophilia A: The LEOPOLD Kids Trial
Thromb Haemost, 123 (1), 27-39
DOI 10.1055/s-0042-1757876, PubMed 36626898
Metastatic rhabdomyosarcoma with exclusive distant lymph node involvement: A European Pediatric Soft tissue sarcoma Study Group (EpSSG) report
Pediatr Blood Cancer, 70 (3), e30143
DOI 10.1002/pbc.30143, PubMed 36519598
Comparison of free-living physical activity measurements between ActiGraph GT3X-BT and Fitbit Charge 3 in young people with haemophilia
Haemophilia, 28 (6), e172-e180
DOI 10.1111/hae.14624, PubMed 35830613
Adolescents and young adults with rhabdomyosarcoma treated in the European paediatric Soft tissue sarcoma Study Group (EpSSG) protocols: a cohort study
Lancet Child Adolesc Health, 6 (8), 545-554
DOI 10.1016/S2352-4642(22)00121-3, PubMed 35690071
Perianal/perineal rhabdomyosarcoma: Results of the SIOP MMT 95, Italian RMS 96, and EpSSG RMS 2005 studies
Pediatr Blood Cancer, 69 (9), e29739
DOI 10.1002/pbc.29739, PubMed 35460336
Brachytherapy for Pediatric Patients at Gustave Roussy Cancer Campus: A Model of International Cooperation for Highly Specialized Treatments
Int J Radiat Oncol Biol Phys, 113 (3), 602-613
DOI 10.1016/j.ijrobp.2022.03.003, PubMed 35278672
Localised rhabdomyosarcoma in infants (<12 months) and young children (12-36 months of age) treated on the EpSSG RMS 2005 study
Eur J Cancer, 160, 206-214
DOI 10.1016/j.ejca.2021.10.031, PubMed 34865946
Informed consent and assent guide for paediatric clinical trials in Europe
Arch Dis Child, 107 (6), 582-590
DOI 10.1136/archdischild-2021-322798, PubMed 34853000
The effect of emicizumab and bypassing agents in patients with hemophilia - An in vitro study
Res Pract Thromb Haemost, 5 (5), e12561
DOI 10.1002/rth2.12561, PubMed 34263107
Non-parameningeal head and neck rhabdomyosarcoma in children, adolescents, and young adults: Experience of the European paediatric Soft tissue sarcoma Study Group (EpSSG) - RMS2005 study
Eur J Cancer, 151, 84-93
DOI 10.1016/j.ejca.2021.04.007, PubMed 33971448
Molecular Characterization of Two Homozygous Factor VII Variants Associated with Intracranial Bleeding
Thromb Haemost, 121 (12), 1588-1598
DOI 10.1055/a-1450-8568, PubMed 33742435
Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience
Eur J Cancer, 146, 21-29
DOI 10.1016/j.ejca.2020.12.025, PubMed 33567392
Life expectancy and cause of death in individuals with haemophilia A and B in Norway, 1986-2018
Eur J Haematol, 105 (5), 608-615
DOI 10.1111/ejh.13494, PubMed 32710483
Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG-RMS2005 study
Cancer Med, 9 (20), 7580-7589
DOI 10.1002/cam4.3365, PubMed 32869534
Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial
Lancet Oncol, 20 (11), 1566-1575
DOI 10.1016/S1470-2045(19)30617-5, PubMed 31562043
Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study
J Pediatr Hematol Oncol, 41 (1), e12-e17
DOI 10.1097/MPH.0000000000001302, PubMed 30550508
Long-term health outcomes in survivors of childhood AML treated with allogeneic HSCT: a NOPHO-AML Study
Bone Marrow Transplant, 54 (5), 726-736
DOI 10.1038/s41409-018-0337-8, PubMed 30242226
Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial
Lancet Oncol, 19 (8), 1061-1071
DOI 10.1016/S1470-2045(18)30337-1, PubMed 29941280
Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)
Cancer, 124 (15), 3201-3209
DOI 10.1002/cncr.31553, PubMed 29797665
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study
Cancer, 124 (5), 1016-1024
DOI 10.1002/cncr.31157, PubMed 29211298
Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 109 /l. The NOPHO experience 1984-2014
Br J Haematol, 178 (3), 448-456
DOI 10.1111/bjh.14692, PubMed 28542715
Access to clinical trials for adolescents with soft tissue sarcomas: Enrollment in European pediatric Soft tissue sarcoma Study Group (EpSSG) protocols
Pediatr Blood Cancer, 64 (6)
DOI 10.1002/pbc.26348, PubMed 27882658
Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Eur J Haematol, 97 (1), 55-62
DOI 10.1111/ejh.12683, PubMed 26383901
Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study
Pediatr Blood Cancer, 61 (9), 1638-43
DOI 10.1002/pbc.25069, PubMed 24760750
Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Pediatr Blood Cancer, 60 (12), 1988-95
DOI 10.1002/pbc.24715, PubMed 24038890
Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia
Br J Haematol, 152 (5), 623-30
DOI 10.1111/j.1365-2141.2010.08554.x, PubMed 21241281
Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study
Pediatr Blood Cancer, 57 (7), 1222-9
DOI 10.1002/pbc.22931, PubMed 22095929
Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003
Br J Haematol, 151 (5), 447-59
DOI 10.1111/j.1365-2141.2010.08389.x, PubMed 20955398
Infections due to various atypical mycobacteria in a Norwegian multiplex family with dominant interferon-gamma receptor deficiency
Clin Infect Dis, 46 (3), e23-7
DOI 10.1086/525855, PubMed 18171304
Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha
Biochim Biophys Acta, 1734 (3), 235-46
DOI 10.1016/j.bbalip.2005.02.011, PubMed 15893958
Involution of thymus and lymphoid depletion in mice expressing the hTNF transgene
APMIS, 112 (1), 63-73
DOI 10.1111/j.1600-0463.2004.apm1120111.x, PubMed 14961977
Human TNF-alpha in transgenic mice induces differential changes in redox status and glutathione-regulating enzymes
FASEB J, 16 (11), 1450-2
DOI 10.1096/fj.01-0948fje, PubMed 12205044
Effects of hTNFalpha expression in T cells on haematopoiesis in transgenic mice
Eur J Haematol, 63 (1), 50-60
DOI 10.1111/j.1600-0609.1999.tb01850.x, PubMed 10414455
[Can type 1 diabetes be prevented?]
Tidsskr Nor Laegeforen, 112 (23), 2951-2
PubMed 1412340
Other articles
Tardy development of safe medicines for children: a Nordic network offers new platform to reduce this inequity
Acta Paediatr, 108 (6), 992-993
DOI 10.1111/apa.14775, PubMed 30844088
Theses
Pleiotropic effects of low, persistent expression of human TNF in transgenic mice
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 138, 1 b. (flere pag.)
BIBSYS 032121024, ISBN 82-8072-096-0